STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 Celltrion's adalimumab-aaty was previously added to the Costco Member Prescription Program in August 2024 JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc....
Read More Details
Finally We wish PressBee provided you with enough information of ( Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program )
Also on site :
- 80s Metal Icons Play Epic First UK Show in 6 Years Ahead of Black Sabbath Opener
- Mel Owens' Ex-Wife Issues Bold Statement on His Upcoming 'Golden Bachelor' Season: 'It's Going to be Bad'
- European retailer inspired by ‘new Med’ hits major milestone opening its 50th store in the US – and 15 more are coming